CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


favipiravirWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug2331 Standard of care therapy Wiki 1.00
drug1907 Previfenon® Wiki 1.00
drug1822 Placebo Wiki 0.06

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Efficacy and Safety of Favipiravir in Management of COVID-19

Randomized controlled interventional trial (Clinical Trial) phase 3 to assess the safety and efficacy of favipiravir versus the standard care therapy in the treatment of patients with COVID-19.

NCT04349241 Coronavirus Disease (COVID-19) Drug: favipiravir Drug: Standard of care therapy
MeSH:Coronavirus Infections

Primary Outcomes

Description: Two successive negative COVID-19 PCR analysis tests 48-72 hours apart

Measure: Viral clearance

Time: 14 days

Description: Normal body temperature for 48 hours

Measure: Clinical improvement

Time: 14 days

Secondary Outcomes

Description: Improvement of radiological abnormalities at day 14

Measure: Radiological Improvement

Time: 14 days


No related HPO nodes (Using clinical trials)